Psychometric Testing and Cue Utilization During Cued Visual Search

September 26, 2024 updated by: Lehigh University
The experimenters will examine the relationship between utilization of positive (target cue) and negative (distractor cue) templates during a cued visual search task with performance on a set of measures related to executive functions associated with attentional control: shifting, updating, and inhibition.

Study Overview

Status

Terminated

Conditions

Intervention / Treatment

Detailed Description

The experimenters will utilize the typical procedures for the cued attentional task, while also deploying the Miyake executive function analysis. Data will also include a working memory capacity measure.

Study Type

Interventional

Enrollment (Actual)

122

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Pennsylvania
      • Bethlehem, Pennsylvania, United States, 18015
        • Lehigh University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Normal or corrected-to-normal visual acuity, normal color vision

Exclusion Criteria:

  • age

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Attentional Tests- Miyake and others
All participants will complete a series of behavioral tasks, including cued visual search with positive, negative, and neutral cues, Miyake executive attention tasks, and a visual working memory task. Single Arm.
Behavioral: Behavioral Measurement
Take measurements of behavioral performance

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Positive, Negative, Neutral Attention Task Performance Speed
Time Frame: 1 day
Reaction times on visual search task with positive, negative, and neutral cues
1 day
Positive, Negative, Neutral Attention Task Performance Accuracy
Time Frame: 1 day
Accuracy on visual search task with positive, negative, and neutral cues
1 day
Miyake Executive Attention task- Updating
Time Frame: 1 day
Updating Attention
1 day
Miyake Executive Attention task-Shifting
Time Frame: 1 day
Shifting Attention
1 day
Miyake Executive Attention task-Inhibition
Time Frame: 1 day
Inhibition of attention
1 day
Working Memory Capacity
Time Frame: 1 day
Estimate of working memory capacity based on behavioral performance
1 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Lehigh University

Investigators

  • Principal Investigator: Nancy Carlisle, PhD, Lehigh University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 12, 2021

Primary Completion (Actual)

August 27, 2022

Study Completion (Actual)

August 27, 2022

Study Registration Dates

First Submitted

April 14, 2021

First Submitted That Met QC Criteria

July 6, 2021

First Posted (Actual)

July 16, 2021

Study Record Updates

Last Update Posted (Actual)

September 27, 2024

Last Update Submitted That Met QC Criteria

September 26, 2024

Last Verified

September 1, 2024

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 1R15EY030247-01A1 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Anonymous behavioral performance data will be available for other researchers upon request

IPD Sharing Time Frame

Upon publication of the work, for at least 5 years

IPD Sharing Access Criteria

Request

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • ANALYTIC_CODE

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on Behavioral Measurement

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ghana

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe